These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 12743146)

  • 1. Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group.
    Fisch MJ; Loehrer PJ; Kristeller J; Passik S; Jung SH; Shen J; Arquette MA; Brames MJ; Einhorn LH;
    J Clin Oncol; 2003 May; 21(10):1937-43. PubMed ID: 12743146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer.
    Holland JC; Romano SJ; Heiligenstein JH; Tepner RG; Wilson MG
    Psychooncology; 1998; 7(4):291-300. PubMed ID: 9741068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy.
    Navari RM; Brenner MC; Wilson MN
    Breast Cancer Res Treat; 2008 Nov; 112(1):197-201. PubMed ID: 18064563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
    Dam J; Ryde L; Svejsø J; Lauge N; Lauritsen B; Bech P
    Pharmacopsychiatry; 1998 Mar; 31(2):48-54. PubMed ID: 9562208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine once every third day in the treatment of major depressive disorder.
    Tural U; Onder E
    Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
    Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
    Nemeroff CB; Thase ME;
    J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Depression after first myocardial infarction. A prospective study on incidence, prognosis, risk factors and treatment].
    Strik JJ; van Praag HM; Honig A
    Tijdschr Gerontol Geriatr; 2003 Jun; 34(3):104-12. PubMed ID: 12866252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.
    Wehmeier PM; Kluge M; Maras A; Riemann D; Berger M; Kohnen R; Dittmann RW; Gattaz WF
    Pharmacopsychiatry; 2005 Jan; 38(1):13-6. PubMed ID: 15706460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure.
    Gottlieb SS; Kop WJ; Thomas SA; Katzen S; Vesely MR; Greenberg N; Marshall J; Cines M; Minshall S
    Am Heart J; 2007 May; 153(5):868-73. PubMed ID: 17452166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
    Amini H; Aghayan S; Jalili SA; Akhondzadeh S; Yahyazadeh O; Pakravan-Nejad M
    J Clin Pharm Ther; 2005 Apr; 30(2):133-8. PubMed ID: 15811165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder.
    Devlin MJ; Goldfein JA; Petkova E; Jiang H; Raizman PS; Wolk S; Mayer L; Carino J; Bellace D; Kamenetz C; Dobrow I; Walsh BT
    Obes Res; 2005 Jun; 13(6):1077-88. PubMed ID: 15976151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind placebo controlled trial of fluoxetine in fibromyalgia.
    Wolfe F; Cathey MA; Hawley DJ
    Scand J Rheumatol; 1994; 23(5):255-9. PubMed ID: 7973479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fluoxetine versus fluvoxamine for treatment of chronic pain].
    Ciaramella A; Grosso S; Poli P
    Minerva Anestesiol; 2000; 66(1-2):55-61. PubMed ID: 10736983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eighteen months of drug treatment for depression: predicting relapse and recovery.
    Mulder RT; Frampton CM; Luty SE; Joyce PR
    J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of quality of life in outpatients with advanced cancer: the accuracy of clinician estimations and the relevance of spiritual well-being--a Hoosier Oncology Group Study.
    Fisch MJ; Titzer ML; Kristeller JL; Shen J; Loehrer PJ; Jung SH; Passik SD; Einhorn LH
    J Clin Oncol; 2003 Jul; 21(14):2754-9. PubMed ID: 12860955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study.
    Brown ES; Vigil L; Khan DA; Liggin JD; Carmody TJ; Rush AJ
    Biol Psychiatry; 2005 Dec; 58(11):865-70. PubMed ID: 15993860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
    ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
    J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.